• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全长重组野生型和突变型扎伊尔埃博拉病毒 VP35 的 dsRNA 结合特性分析。

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.

机构信息

Department of Life and Environmental Sciences, University of Cagliari, Cittadella di Monserrato SS554, 09042 Monserrato, Cagliari, Italy.

出版信息

Antiviral Res. 2012 Mar;93(3):354-63. doi: 10.1016/j.antiviral.2012.01.005. Epub 2012 Jan 25.

DOI:10.1016/j.antiviral.2012.01.005
PMID:22289166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7114247/
Abstract

The Ebola viruses (EBOVs) VP35 protein is a multifunctional major virulence factor involved in EBOVs replication and evasion of the host immune system. EBOV VP35 is an essential component of the viral RNA polymerase, it is a key participant of the nucleocapsid assembly and it inhibits the innate immune response by antagonizing RIG-I like receptors through its dsRNA binding function and, hence, by suppressing the host type I interferon (IFN) production. Insights into the VP35 dsRNA recognition have been recently revealed by structural and functional analysis performed on its C-terminus protein. We report the biochemical characterization of the Zaire ebolavirus (ZEBOV) full-length recombinant VP35 (rVP35)-dsRNA binding function. We established a novel in vitro magnetic dsRNA binding pull down assay, determined the rVP35 optimal dsRNA binding parameters, measured the rVP35 equilibrium dissociation constant for heterologous in vitro transcribed dsRNA of different length and short synthetic dsRNA of 8bp, and validated the assay for compound screening by assessing the inhibitory ability of auryntricarboxylic acid (IC(50) value of 50μg/mL). Furthermore, we compared the dsRNA binding properties of full length wt rVP35 with those of R305A, K309A and R312A rVP35 mutants, which were previously reported to be defective in dsRNA binding-mediated IFN inhibition, showing that the latter have measurably increased K(d) values for dsRNA binding and modified migration patterns in mobility shift assays with respect to wt rVP35. Overall, these results provide the first characterization of the full-length wt and mutants VP35-dsRNA binding functions.

摘要

埃博拉病毒(EBOV)VP35 蛋白是一种多功能的主要毒力因子,参与 EBOV 的复制和逃避宿主免疫系统。EBOV VP35 是病毒 RNA 聚合酶的一个重要组成部分,它是核衣壳组装的关键参与者,通过其 dsRNA 结合功能拮抗 RIG-I 样受体,从而抑制先天免疫反应,因此抑制宿主 I 型干扰素(IFN)的产生。最近对其 C 末端蛋白进行的结构和功能分析揭示了 VP35 dsRNA 识别的见解。我们报告了扎伊尔埃博拉病毒(ZEBOV)全长重组 VP35(rVP35)-dsRNA 结合功能的生化特征。我们建立了一种新颖的体外磁性 dsRNA 结合下拉测定法,确定了 rVP35 最佳 dsRNA 结合参数,测量了 rVP35 对不同长度和 8bp 短合成 dsRNA 的异源体外转录 dsRNA 的平衡解离常数,并通过评估auryntricarboxylic 酸的抑制能力(IC(50)值为 50μg/mL)验证了该测定法用于化合物筛选。此外,我们比较了全长 wt rVP35 与 R305A、K309A 和 R312A rVP35 突变体的 dsRNA 结合特性,这些突变体先前被报道在 dsRNA 结合介导的 IFN 抑制中存在缺陷,结果表明后者的 dsRNA 结合 K(d)值显著增加,并且在迁移率变动分析中与 wt rVP35 相比迁移模式发生了改变。总的来说,这些结果首次对全长 wt 和突变体 VP35-dsRNA 结合功能进行了表征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/ced9227b19f2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/5a9cb0135693/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/c8607a6b2cec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/bc0b756d7aed/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/f3c283d5b3ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/c5ab50ecaee4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/ced9227b19f2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/5a9cb0135693/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/c8607a6b2cec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/bc0b756d7aed/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/f3c283d5b3ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/c5ab50ecaee4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca42/7114247/ced9227b19f2/gr6.jpg

相似文献

1
dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.全长重组野生型和突变型扎伊尔埃博拉病毒 VP35 的 dsRNA 结合特性分析。
Antiviral Res. 2012 Mar;93(3):354-63. doi: 10.1016/j.antiviral.2012.01.005. Epub 2012 Jan 25.
2
Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.通过一种基于新型荧光的检测方法鉴定杨梅素为埃博拉病毒VP35-双链RNA相互作用抑制剂。
Biochemistry. 2018 Nov 6;57(44):6367-6378. doi: 10.1021/acs.biochem.8b00892. Epub 2018 Oct 22.
3
Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.突变使埃博拉病毒的 VP35 蛋白与双链 RNA 的相互作用失效,从而使病毒丧失毒力。
J Virol. 2010 Mar;84(6):3004-15. doi: 10.1128/JVI.02459-09. Epub 2010 Jan 13.
4
Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation.VP35 IID相互作用与识别双链RNA的微观机制探索:分子动力学模拟
Proteins. 2017 Jun;85(6):1008-1023. doi: 10.1002/prot.25269. Epub 2017 Mar 7.
5
Structure of the Ebola VP35 interferon inhibitory domain.埃博拉病毒VP35干扰素抑制结构域的结构
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):411-6. doi: 10.1073/pnas.0807854106. Epub 2009 Jan 2.
6
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.埃博拉病毒VP35蛋白结合双链RNA并抑制由RIG-I信号通路诱导产生的α/β干扰素。
J Virol. 2006 Jun;80(11):5168-78. doi: 10.1128/JVI.02199-05.
7
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.埃博拉病毒 VP35 蛋白与 RIG-I 激活剂 PACT 之间的相互拮抗决定了感染结果。
Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.
8
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.埃博拉病毒 VP35 识别 dsRNA 和拮抗干扰素的结构基础。
Nat Struct Mol Biol. 2010 Feb;17(2):165-72. doi: 10.1038/nsmb.1765. Epub 2010 Jan 17.
9
Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.埃博拉病毒 VP35 采用双模策略结合 dsRNA 进行先天免疫抑制。
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):314-9. doi: 10.1073/pnas.0910547107. Epub 2009 Dec 14.
10
Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.埃博拉病毒VP35抑制人树突状细胞成熟的分子基础
J Virol. 2014 Nov;88(21):12500-10. doi: 10.1128/JVI.02163-14. Epub 2014 Aug 20.

引用本文的文献

1
Ebola and Marburg virus VP35 coiled-coil validated as antiviral target by tripartite split-GFP complementation.通过三方分裂绿色荧光蛋白互补验证埃博拉病毒和马尔堡病毒VP35卷曲螺旋结构作为抗病毒靶点
iScience. 2022 Oct 13;25(11):105354. doi: 10.1016/j.isci.2022.105354. eCollection 2022 Nov 18.
2
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.埃博拉病毒VP35同源二聚化对I型干扰素级联反应抑制的相关性
Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619889220. doi: 10.1177/2040206619889220.
3
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.

本文引用的文献

1
Current perspectives on the phylogeny of Filoviridae.丝状病毒科的系统发育研究现状。
Infect Genet Evol. 2011 Oct;11(7):1514-9. doi: 10.1016/j.meegid.2011.06.017. Epub 2011 Jun 30.
2
Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.埃博拉和马尔堡出血热病毒:重大科学进展,但对非洲来说,公共卫生威胁相对较小。
Clin Microbiol Infect. 2011 Jul;17(7):964-76. doi: 10.1111/j.1469-0691.2011.03535.x.
3
Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.
识别扎伊尔埃博拉丝状病毒 VP35 蛋白的细胞内人抗体片段抑制该蛋白的活性。
BMC Biotechnol. 2019 Sep 5;19(1):64. doi: 10.1186/s12896-019-0554-2.
4
Ebola virus VP35 has novel NTPase and helicase-like activities.埃博拉病毒 VP35 具有新型 NTPase 和 helicase 样活性。
Nucleic Acids Res. 2019 Jun 20;47(11):5837-5851. doi: 10.1093/nar/gkz340.
5
Broad-range potential of Asphodelus microcarpus leaves extract for drug development.小果阿福花叶片提取物在药物开发方面具有广泛的潜力。
BMC Microbiol. 2017 Jul 14;17(1):159. doi: 10.1186/s12866-017-1068-5.
6
RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.埃博拉病毒VP30的RNA结合对于激活病毒转录至关重要。
J Virol. 2016 Jul 27;90(16):7481-7496. doi: 10.1128/JVI.00271-16. Print 2016 Aug 15.
7
The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs.寻求有效的埃博拉治疗方法:埃博拉病毒VP35蛋白是双链RNA药物的一个循证靶点。
Emerg Microbes Infect. 2014 Oct;3(10):e77. doi: 10.1038/emi.2014.77. Epub 2014 Oct 29.
8
Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.在VP35的IID区域含有突变的重组马尔堡病毒可防止宿主免疫反应受到抑制。
Virology. 2015 Feb;476:85-91. doi: 10.1016/j.virol.2014.12.002. Epub 2014 Dec 19.
9
Viral proteins that bind double-stranded RNA: countermeasures against host antiviral responses.结合双链RNA的病毒蛋白:对抗宿主抗病毒反应的对策
J Interferon Cytokine Res. 2014 Jun;34(6):464-8. doi: 10.1089/jir.2014.0005.
10
Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit.高致病性 RNA 病毒阻断 RIG-I 样受体识别 dsRNA 的策略:隐藏、伪装、攻击。
Antiviral Res. 2013 Dec;100(3):615-35. doi: 10.1016/j.antiviral.2013.10.002. Epub 2013 Oct 12.
三种非人类灵长类动物中扎伊尔埃博拉病毒的气溶胶暴露:疾病过程和临床病理学的差异。
Microbes Infect. 2011 Oct;13(11):930-6. doi: 10.1016/j.micinf.2011.05.002. Epub 2011 May 25.
4
Immune signaling by RIG-I-like receptors.RIG-I 样受体的免疫信号转导。
Immunity. 2011 May 27;34(5):680-92. doi: 10.1016/j.immuni.2011.05.003.
5
Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs.扎伊尔埃博拉病毒在猪体内的复制、致病性、脱落和传播。
J Infect Dis. 2011 Jul 15;204(2):200-8. doi: 10.1093/infdis/jir077. Epub 2011 May 12.
6
Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.埃博拉病毒蛋白通过与哺乳动物 RNA 干扰途径的直接相互作用来抑制小干扰 RNA 的作用。
J Virol. 2011 Mar;85(6):2512-23. doi: 10.1128/JVI.01160-10. Epub 2011 Jan 12.
7
Ebolavirus VP35 is a multifunctional virulence factor.埃博拉病毒 VP35 是一种多功能毒力因子。
Virulence. 2010 Nov-Dec;1(6):526-31. doi: 10.4161/viru.1.6.12984. Epub 2010 Nov 1.
8
Progress in filovirus vaccine development: evaluating the potential for clinical use.丝状病毒疫苗研发进展:评估临床应用潜力。
Expert Rev Vaccines. 2011 Jan;10(1):63-77. doi: 10.1586/erv.10.152.
9
Ebola haemorrhagic fever.埃博拉出血热。
Lancet. 2011 Mar 5;377(9768):849-62. doi: 10.1016/S0140-6736(10)60667-8.
10
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.关于丝状病毒科分类的修订提案:分类、分类群名称和病毒名称以及病毒缩写。
Arch Virol. 2010 Dec;155(12):2083-103. doi: 10.1007/s00705-010-0814-x. Epub 2010 Oct 30.